V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10028309 | 10063589 | 1.72 | 87.1 | Adjuvant (A) | 2020-01-27 | 2020-01-27 | Avelumab | 02 | N | CARBOPLATIN + GEMCITABINE | 101306915 |
| 10030463 | 10063590 | 1.53 | 96 | Palliative (P) | 2021-04-24 | 2021-04-27 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100517013 |
| 10033232 | 10063591 | 1.65 | 56.4 | null | 2020-06-03 | 2020-06-21 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101210887 |
| 10037048 | 10063592 | 1.55 | 0 | null | 2016-07-04 | 2018-09-01 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 101344549 |
| 10037125 | 10063593 | 1.77 | 84.55 | 03 | null | 2019-11-07 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100293882 |
| 10037227 | 10063594 | 1.69 | 74.95 | Palliative (P) | 2020-07-14 | 2020-09-08 | Venetoclax | 02 | N | VENETOCLAX | 101371464 |
| 10042327 | 10063595 | 1.5 | 85.2 | null | 2015-03-09 | 2019-07-18 | Venetoclax | 02 | null | VENETOCLAX | 101033870 |
| 10043105 | 10063596 | 1.62 | 55.9 | null | 2019-08-08 | 2019-09-13 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 101317416 |
| 10044128 | 10063597 | 0 | 92.7 | null | 2019-05-06 | 2019-05-08 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100329229 |
| 10044381 | 10063598 | 1.83 | 80.4 | Palliative (P) | 2019-05-13 | 2019-05-18 | NIVOLUMAB | 99 | N | NIVOLUMAB | 100593323 |
| 10044385 | 10063599 | 1.74 | 92 | null | 2018-10-05 | 2019-06-08 | Oxaliplatin + Modified de Gramont | 02 | null | FLUOROURACIL + OXALIPLATIN | 100335862 |
| 10047815 | 10063601 | 1.71 | 64.8 | null | 2022-04-21 | 2022-04-29 | Avelumab | 02 | N | TRASTUZUMAB | 101098508 |
| 10049798 | 10063603 | 1.76 | 97 | null | 2020-12-28 | 2021-01-17 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 100625952 |
| 10049955 | 10063604 | 1.58 | 100 | 03 | 2020-04-11 | 2020-04-17 | Capecitabine + Oxaliplatin 14day | 02 | N | CAPECITABINE + OXALIPLATIN | 100427532 |
| 10051750 | 10063606 | 1.55 | 91.4 | null | 2019-01-16 | 2019-03-05 | Avelumab | 02 | null | NIVOLUMAB | 100309116 |
| 10055637 | 10063609 | 1.65 | 61 | 03 | 2020-06-28 | 2020-07-02 | Trastuzumab Subcutaneous | 02 | N | CAPECITABINE + OXALIPLATIN | 101433600 |
| 10058477 | 10063612 | 1.51 | 72.5 | Palliative (P) | 2015-11-08 | 2016-03-23 | DARATUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN | 101737185 |
| 10064100 | 10063616 | 1.7 | 68.8 | 02 | 2017-03-22 | 2017-08-27 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100807441 |
| 10070902 | 10063617 | 1.73 | 79.8 | Adjuvant (A) | 2018-05-11 | 2018-08-29 | Avelumab | 02 | N | VENETOCLAX | 100591661 |
| 10072681 | 10063618 | 1.58 | 64.7 | null | 2021-07-27 | 2021-09-25 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100635331 |
| 10072850 | 10063619 | 1.83 | 80.1 | Neo-adjuvant (N) | 2021-01-15 | 2021-04-16 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101453929 |
| 10073652 | 10063620 | 1.57 | 109.7 | null | 2019-12-23 | 2020-01-07 | Venetoclax | 02 | null | CARBOPLATIN + GEMCITABINE | 101210565 |
| 10075178 | 10063622 | 0 | 60 | Adjuvant (A) | 2021-02-08 | 2021-02-10 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 101049512 |
| 10076213 | 10063623 | 1.74 | 41.5 | null | 2016-06-11 | 2016-08-09 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 100544266 |
| 10078362 | 10063624 | 1.71 | 79.3 | null | 2021-03-27 | 2022-04-17 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101363598 |
| 10079881 | 10063626 | 1.74 | 49.2 | null | 2022-01-14 | 2022-05-27 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101736314 |
| 10085293 | 10063628 | 1.56 | 70.9 | Palliative (P) | 2021-05-07 | 2021-05-27 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101221821 |
| 10085784 | 10063629 | 1.62 | 72 | Palliative (P) | 2019-09-03 | 2019-10-05 | Trastuzumab | 02 | N | TRASTUZUMAB | 101350165 |
| 10087201 | 10063630 | 1.65 | 101 | Palliative (P) | 2019-08-03 | 2019-08-23 | Avelumab | 02 | N | DARATUMUMAB | 100557359 |
| 10088269 | 10063631 | null | 55.6 | Palliative (P) | null | 2022-02-07 | Bendamustine+Rituximab (1st Course) | 02 | N | BENDAMUSTINE + RITUXIMAB | 100491814 |
| 10089404 | 10063632 | 1.5 | 92 | Palliative (P) | 2021-02-22 | 2021-08-02 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 100052302 |
| 10090872 | 10063633 | 1.58 | 77 | Adjuvant (A) | 2014-10-06 | 2018-02-18 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101735264 |
| 10091197 | 10063634 | 1.56 | 66.2 | Adjuvant (A) | 2020-07-06 | 2020-08-03 | Venetoclax | 02 | N | AVELUMAB | 101301313 |
| 10092366 | 10063635 | 1.83 | 77.7 | Palliative (P) | 2017-11-17 | 2017-11-20 | Venetoclax | 02 | N | VENETOCLAX | 100089556 |
| 10094433 | 10063636 | 1.91 | 72.5 | null | null | 2021-04-09 | Oxaliplatin + Modified de Gramont | 02 | null | FLUOROURACIL + OXALIPLATIN | 101151816 |
| 10094662 | 10063637 | 0 | 75 | 03 | 2020-04-02 | 2021-01-04 | Avelumab | 02 | N | TRASTUZUMAB | 100723532 |
| 10097910 | 10063639 | 1.55 | 60 | Palliative (P) | 2021-06-13 | 2021-06-24 | Avelumab | 02 | N | RUXOLITINIB | 101086136 |
| 10100653 | 10063640 | 1.71 | 61.2 | 03 | 2019-05-09 | 2019-06-16 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 101035928 |
| 10102958 | 10063642 | 0 | 66.2 | null | 2021-09-28 | 2021-10-12 | Bendamustine+Rituximab(Sub Courses) | 02 | null | BENDAMUSTINE + RITUXIMAB | 101538390 |
| 10103476 | 10063643 | 1.69 | 45.8 | Palliative (P) | 2020-10-20 | 2020-10-20 | DARATUMUMAB | 02 | N | CARBOPLATIN + GEMCITABINE | 100440302 |
| 10103791 | 10063644 | 1.77 | 75 | null | 2020-01-19 | 2020-10-08 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100036702 |
| 10105330 | 10063645 | 1.49 | 77.7 | null | 2020-02-28 | 2020-03-25 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101353414 |
| 10105476 | 10063646 | 1.63 | 62.5 | Palliative (P) | 2018-04-17 | 2018-06-10 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100594114 |
| 10106203 | 10063647 | 1.81 | 54 | Palliative (P) | 2018-06-19 | 2018-06-23 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100263461 |
| 10107671 | 10063648 | 1.87 | 67 | 03 | 2019-03-08 | 2019-05-18 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100140242 |
| 10111204 | 10063650 | 0 | 78.6 | null | 2018-11-30 | 2018-12-01 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101171373 |
| 10113033 | 10063651 | 1.72 | 65.5 | Palliative (P) | 2019-11-01 | 2019-11-22 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100409317 |
| 10114484 | 10063652 | 1.59 | 71 | Palliative (P) | 2019-06-01 | 2019-08-02 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100430739 |
| 10118194 | 10063653 | 1.59 | 66 | Curative (C) | 2019-08-10 | 2019-08-15 | Avelumab | 02 | N | CEMIPLIMAB | 100899876 |
| 10120299 | 10063654 | 1.62 | 59.2 | Palliative (P) | 2019-12-19 | 2020-05-23 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101833148 |